Oncologix Tech, Inc. Share Price Other OTC
Equities
OCLG
US68230M2098
Investment Holding Companies
Sales 2013 | 0.24 19.46 | Sales 2014 | 3.68 293.07 | Capitalization | 758K 60.41M |
---|---|---|---|---|---|
Net income 2013 | - 0 | Net income 2014 | -1M -79.69M | EV / Sales 2013 | 8,716,069 x |
Net Debt 2013 | 1.33M 106M | Net Debt 2014 | 1.89M 151M | EV / Sales 2014 | 721,342 x |
P/E ratio 2013 |
-1.03
x | P/E ratio 2014 |
-0.47
x | Employees | - |
Yield 2013 * |
-
| Yield 2014 |
-
| Free-Float | 99% |
Managers | Title | Age | Since |
---|---|---|---|
Frank Igwealor
CEO | Chief Executive Officer | 53 | 24/06/21 |
Nikole Jessie
IRO | Public Communications Contact | - | 31/05/15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Frank Igwealor
CEO | Chief Executive Officer | 53 | 24/06/21 |
1st Jan change | Capi. | |
---|---|---|
+167.97% | 6.65B | |
+2.00% | 981M | |
+2.45% | 928M | |
+41.91% | 872M | |
+16.80% | 804M | |
+1.91% | 664M | |
-.--% | 600M | |
-2.15% | 593M | |
+31.63% | 552M |